Ampio Pharma off 5.4% as it prices secondary

The 8.5M share secondary offering is priced at $7 per share for gross proceeds of $59.5M, and net proceeds expected to be about $55M. This doesn't include the greenshoe to bookrunners Citi and Jefferies of 1.275M shares.

AMPE -5.4% premarket to $7.51 per share

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs